Atlas

FDA-Inspected Site

Meridian Medical Technologies, LLC

23 FDA inspections are on record for Meridian Medical Technologies, LLC in Saint Louis, United States.

483· Form 483 issued

Saint Louis, United States · Last updated July 9, 2026

Overview

  • 23 FDA inspections are on record.
  • 14 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-06-05.

At a glance

Inspections

23

Form 483s

14

EIRs

3

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
20 May 2024 – 5 Jun 2024Human Drugs483View 483 →
9 Dec 2019 – 21 Dec 2019Medical Devices & Rad Health483View 483 →
6 May 2019 – 6 Jun 2019Human Drugs483View 483 →
20 Feb 2017 – 24 Mar 2017Medical Devices & Rad HealthWLView 483 →
13 Mar 2015 – 23 Mar 2015Human Drugs483On file
14 Oct 2014 – 25 Nov 2014Medical Devices & Rad Health483View 483 →
27 Jan 2014 – 21 Feb 2014Medical Devices & Rad Health483On file
26 Sep 2013 – 9 Oct 2013Human Drugs483On file
25 Sep 2013 – 9 Oct 2013Human Drugs483On file
20 Mar 2013 – 29 Apr 2013Human DrugsClean
24 Jan 2013 – 4 Mar 2013Medical Devices & Rad Health483On file
13 Feb 2012Not recorded483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

5 Jun 2024
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Robert J Ham, Joohi Castelvetere, Monica C Burgos Garcia, Jacob G Lutz, Karen M Cruz Arenas

5 Jun 2024
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Robert J Ham, Joohi Castelvetere, Monica C Burgos Garcia, Jacob G Lutz, Karen M Cruz Arenas

5 Jun 2024
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Robert J Ham, Joohi Castelvetere, Monica C Burgos Garcia, Jacob G Lutz, Karen M Cruz Arenas

5 Jun 2024
21 CFR 211.165(d)

Acceptance criteria for sampling & testing

Cited by Robert J Ham, Joohi Castelvetere, Monica C Burgos Garcia, Jacob G Lutz, Karen M Cruz Arenas

5 Jun 2024
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Robert J Ham, Joohi Castelvetere, Monica C Burgos Garcia, Jacob G Lutz, Karen M Cruz Arenas

Investigators

FDA investigators tied to this site in the record.

Michele Perry-Williams6 insp.
Kathleen B Swat4 insp.
Robert J Ham3 insp.
Michele Perry Williams3 insp.
Sherry G Bous3 insp.
Shirley J Berryman3 insp.
Eric M Padgett2 insp.
Matthew Ondeck2 insp.
Sandra A Hughes2 insp.
Rick L Friedman2 insp.
Phillip M Pontikos2 insp.
Michele L Obert2 insp.
Steven D Kehoe2 insp.
Joohi Castelvetere1 insp.
Monica C Burgos Garcia1 insp.
Jacob G Lutz1 insp.
Karen M Cruz Arenas1 insp.
Joseph R Strelnik1 insp.
Edward E Lockwood1 insp.
Rohit B Kolhatkar1 insp.
Alex M Viehmann1 insp.
Sandra A Boyd1 insp.
Kellia N Hicks1 insp.
Zedong Dong1 insp.
John C Mcmichael1 insp.
Frank Wackes1 insp.
Dawn C Olenjack1 insp.
Cntrctmntr K Concannon1 insp.
Zachary A Bogorad1 insp.
Eric M Mueller1 insp.
Thomas J Arista1 insp.
James D Planchon1 insp.
Anthony Bucks1 insp.
Amir A Abdalla1 insp.
Justin A Boyd1 insp.
Matthew H Hunt1 insp.
Erika V Butler1 insp.
Blondell W Johnson1 insp.
Kara L Roden1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.30(g)Cited across public-safe Form 483 observations11x
21 CFR 211.113(b)Cited across public-safe Form 483 observations10x
21 CFR 820.30(f)Cited across public-safe Form 483 observations10x
21 CFR 211.192Cited across public-safe Form 483 observations9x
21 CFR 211.22(a)Cited across public-safe Form 483 observations8x
21 CFR 211.100(b)Cited across public-safe Form 483 observations7x
21 CFR 211.110(a)Cited across public-safe Form 483 observations7x
21 CFR 820.198(a)Cited across public-safe Form 483 observations7x
21 CFR 820.75(a)Cited across public-safe Form 483 observations7x
21 CFR 211.25(a)Cited across public-safe Form 483 observations6x
21 CFR 820.100(a)Cited across public-safe Form 483 observations6x
21 CFR 820.50Cited across public-safe Form 483 observations6x
21 CFR 211.198(a)Cited across public-safe Form 483 observations5x
21 CFR 211.160(b)Cited across public-safe Form 483 observations4x
21 CFR 820.30(d)Cited across public-safe Form 483 observations4x
21 CFR 211.165(d)Cited across public-safe Form 483 observations3x
21 CFR 211.166(a)(3)Cited across public-safe Form 483 observations3x
21 CFR 211.180(e)Cited across public-safe Form 483 observations3x
21 CFR 314.81(b)(1)(ii)Cited across public-safe Form 483 observations3x
21 CFR 820.250(a)Cited across public-safe Form 483 observations3x
21 CFR 820.30(c)Cited across public-safe Form 483 observations3x
21 CFR 820.30(h)Cited across public-safe Form 483 observations3x
21 CFR 820.80(b)Cited across public-safe Form 483 observations3x
21 CFR 820.80(d)Cited across public-safe Form 483 observations3x
21 CFR 820.90(a)Cited across public-safe Form 483 observations3x
21 CFR 211.63Cited across public-safe Form 483 observations2x
21 CFR 211.68(b)Cited across public-safe Form 483 observations2x
21 CFR 211.84(a)Cited across public-safe Form 483 observations2x
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.182Cited across public-safe Form 483 observations1x
21 CFR 211.198(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.58Cited across public-safe Form 483 observations1x
21 CFR 211.80(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Meridian Medical Technologies, LLC's 14 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat